Direxion Daily Healthcare Bull 3x Shares (NYSEARCA:CURE) Trading 5.7% Higher – Should You Buy?

Direxion Daily Healthcare Bull 3x Shares (NYSEARCA:CURE)’s stock price traded up 5.7% on Tuesday . The company traded as high as $91.91 and last traded at $91.57. 47,917 shares traded hands during mid-day trading, a decline of 11% from the average session volume of 54,071 shares. The stock had previously closed at $86.64.

Direxion Daily Healthcare Bull 3x Shares Stock Up 5.7%

The stock has a fifty day simple moving average of $106.93 and a 200-day simple moving average of $103.47. The company has a market capitalization of $137.36 million, a P/E ratio of 20.81 and a beta of 1.91.

Hedge Funds Weigh In On Direxion Daily Healthcare Bull 3x Shares

Hedge funds and other institutional investors have recently bought and sold shares of the business. Headlands Technologies LLC bought a new stake in shares of Direxion Daily Healthcare Bull 3x Shares in the 2nd quarter valued at $34,000. Frazier Financial Advisors LLC bought a new position in Direxion Daily Healthcare Bull 3x Shares during the fourth quarter worth about $112,000. Qube Research & Technologies Ltd acquired a new position in Direxion Daily Healthcare Bull 3x Shares in the second quarter valued at about $157,000. EverSource Wealth Advisors LLC grew its stake in Direxion Daily Healthcare Bull 3x Shares by 16.2% in the second quarter. EverSource Wealth Advisors LLC now owns 2,150 shares of the company’s stock valued at $169,000 after acquiring an additional 300 shares during the period. Finally, Onyx Bridge Wealth Group LLC bought a new stake in shares of Direxion Daily Healthcare Bull 3x Shares in the third quarter worth about $206,000.

About Direxion Daily Healthcare Bull 3x Shares

The Direxion Daily Healthcare Bull 3X Shares (CURE) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund provides 3x levered exposure to a market cap weighted sub-index of the S&P 500 that tracks the performance of US listed health care companies. CURE was launched on Jun 15, 2011 and is managed by Direxion.